Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade

Overview of attention for article published in Journal for Immunotherapy of Cancer, June 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#23 of 2,934)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 28 tweets from 25 users, with an upper bound of 86,704 followers.

RT @niklas_kluemper: Exciting study on an early on-treatment biomarker for predicting immunotherapy response in NSCLC. Dynamic inflammatory…

RT @APDicker: Congratulations to the entire team @OncoHost @Technion @KimmelCancerCtr @jeffradonc @OSUCCC_James for this beautiful work in…

RT @weldeiry: Longitudinal plasma proteomic profiling of patients w/ NSCLC undergoing ICB ⁦@JerryAzzoli⁩ ⁦@drabbaseabbas⁩ ⁦@HinaKhanMD⁩ ⁦@L…

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 24 additional tweets.